<code id='A032DA15B0'></code><style id='A032DA15B0'></style>
    • <acronym id='A032DA15B0'></acronym>
      <center id='A032DA15B0'><center id='A032DA15B0'><tfoot id='A032DA15B0'></tfoot></center><abbr id='A032DA15B0'><dir id='A032DA15B0'><tfoot id='A032DA15B0'></tfoot><noframes id='A032DA15B0'>

    • <optgroup id='A032DA15B0'><strike id='A032DA15B0'><sup id='A032DA15B0'></sup></strike><code id='A032DA15B0'></code></optgroup>
        1. <b id='A032DA15B0'><label id='A032DA15B0'><select id='A032DA15B0'><dt id='A032DA15B0'><span id='A032DA15B0'></span></dt></select></label></b><u id='A032DA15B0'></u>
          <i id='A032DA15B0'><strike id='A032DA15B0'><tt id='A032DA15B0'><pre id='A032DA15B0'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:45
          Influenza A virions
          F. A. Murphy/CDC

          Vir Biotechnology said Thursday that a long-acting antibody drug designed to protect healthy individuals from influenza A failed to do so in a nearly 3,000-person clinical trial.

          Volunteers who received the highest dose of the drug, known as VIR-2482, were only 16% less likely than the placebo group to develop symptomatic influenza A infections, as defined by trial criteria, over a seven-month period. The difference was not statistically significant.

          advertisement

          The results are a setback in broader efforts to develop better protective measures against both seasonal and potential pandemic influenza strains. In the short term, Vir and outside experts hoped VIR-2482 could provide additional annual protection for at-risk groups like older adults, as flu vaccines are often only modestly effective.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Just how do doctors, lawmakers, and the public define abortion?
          Just how do doctors, lawmakers, and the public define abortion?

          Anexamroominawomen'shealthcenterinIndiana,whereabortionsarenowbannedwithverylimitedexceptions.ScottO

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          CDC marks new Covid

          ACovidtestingsiteinNewYorkCity.SpencerPlatt/GettyImagesPeoplewhoarenotuptodatewiththeirCovid-19vacci